TUBAP1

Across TCGA pan-cancer cohorts, TUBAP1 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated TUBAP1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher TUBAP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TUBAP1 expression acts as an unfavorable survival marker, although some lineages such as OV and HNSC show a favorable association.

MESO, PAAD, and STAD are the cancer types where TUBAP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.362	0.605	.003	117	view →
PAAD	OS	Tertile	All	0.238	0.516	<.001	66	view →
STAD	DFS	Median	All	0.470	0.629	.001	36	view →
UCS	OS	Tertile	III,IV	0.291	0.661	.010	36	view →
UCEC	DFS	Tertile	IV	0.314	0.775	<.001	36	view →
PCPG	OS	Tertile	All	0.318	0.981	<.001	33	view →
DLBC	DFS	Tertile	II,III,IV	0.349	0.819	.006	25	view →
OV	OS	Quartile	IV	0.663	0.324	.002	20	view →
READ	OS	Tertile	IV	0.541	0.914	.024	18	view →
LUSC	OS	Quartile	III,IV	0.238	0.870	.001	11	view →
HNSC	DFS	Tertile	IV	0.581	0.324	.019	10	view →
BLCA	DFS	Tertile	IV	0.219	0.549	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

TUBAP1–MESO (OS)

Open the MESO breakdown →